Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
jueves, octubre 01
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Inogen Inc
INGN
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$5.27
-0.10
-1.86%
Últ. Act.: Sep 30, 7:58 PM
$5.68
0.31
5.73%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
Fusiones y adquisiciones:
Inogen (INGN) announced it will sell assets to Rotech Healthcare, on Wednesday, September 30, 2026 for $25M paid in cash
Inogen Financials
Inogen (INGN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
Inogen (NASDAQ:INGN) lowers FY2026 sales outlook from $366.000 million-$373.000 million to $355.000 million-$361.000 million vs $369.267 million estimate.
Benzinga Newsdesk
PRO
Inogen Sees Q3 Sales $92.400M vs $98.967M Est
Inogen (NASDAQ:INGN) sees Q3 sales of $92.400 million vs $98.967 million analyst estimate.
Benzinga Newsdesk
PRO
Inogen Q2 Sales $95.084M Miss $95.233M Estimate
Inogen (NASDAQ:INGN) reported quarterly sales of $95.084 million which missed the analyst consensus estimate of $95.233 million by 0.16 percent. This is a 3.04 percent increase over sales of $92.277 million the same
Benzinga Newsdesk
PRO
Inogen Affirms FY2026 Sales Guidance of $366.000M-$373.000M vs $369.267M Est
Inogen (NASDAQ:INGN) affirms FY2026 sales outlook from $366.000 million-$373.000 million to $366.000 million-$373.000 million vs $369.267 million estimate.
Benzinga Newsdesk
PRO
Inogen Sees Q2 Sales $94.000M-$97.000M vs $97.250M Est
Inogen (NASDAQ:INGN) sees Q2 sales of $94.000 million-$97.000 million vs $97.250 million analyst estimate.
Benzinga Newsdesk
PRO
Inogen Q1 Adj. EPS $(0.14) Beats $(0.28) Estimate, Sales $85.109M Beat $82.350M Estimate
Inogen (NASDAQ:INGN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.28) by 50 percent. This is a 27.27 percent decrease over losses of $(0.11) per share from the same
Benzinga Newsdesk
